OncoCyte Corporation (OCX)
| Bid | 3.26 |
| Market Cap | 97.24M |
| Revenue (ttm) | 1.88M |
| Net Income (ttm) | -60.66M |
| EPS (ttm) | -4.66 |
| PE Ratio (ttm) | -0.73 |
| Forward PE | -3.31 |
| Analyst | Buy |
| Ask | 3.55 |
| Volume | 165,891 |
| Avg. Volume (20D) | 82,049 |
| Open | 3.05 |
| Previous Close | 2.95 |
| Day's Range | 3.05 - 3.43 |
| 52-Week Range | 1.92 - 4.75 |
| Beta | 0.98 |
About OCX
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support...
Analyst Forecast
According to 3 analyst ratings, the average rating for OCX stock is "Buy." The 12-month stock price forecast is $4.25, which is an increase of 25.00% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · prismmediawire.com
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare ConferenceIRVINE, Calif., April 2, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Of...
1 month ago · prismmediawire.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 CatalystsIRVINE, Calif., March 24, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its fourth q...
1 month ago · prismmediawire.com
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025IRVINE, Calif., March 18, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it will report fourth quarter 2024 financial results ...
2 months ago · prismmediawire.com
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceIRVINE, Calif., Feb. 11, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial...
